Zenlabs Ethica Limited

Equities

ZENLABS6

INE546F01013

Pharmaceuticals

Market Closed - Bombay S.E. 12:09:10 2024-07-09 am EDT 5-day change 1st Jan Change
41.05 INR +0.47% Intraday chart for Zenlabs Ethica Limited +1.33% -0.85%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Zenlabs Ethica Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Zenlabs Ethica Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Zenlabs Ethica Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Zenlabs Ethica Limited Announces Resignation of Ashok Gupta as Independent Director of the Company with Immediate Effect from the Close of Business Hours of 18Th October 2023 CI
Hitesh Popatlal Oswal Leaves His Position of Additional Director from Additional Director CI
Zenlabs Ethica Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Zenlabs Ethica Appoints CFO MT
Zenlabs Ethica Limited Announces Executive Changes CI
Zenlabs Ethica Limited Appoints Askhay Saxena as Company Secretary Cum Compliance Officer CI
Zenlabs Ethica Limited Announces CFO Changes CI
Zenlabs Ethica Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Zenlabs Ethica Limited Announces Resignation of Tanvi Chhabra from the Post of Company Secretary & Compliance Officer CI
Zenlabs Ethica Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Zenlabs Ethica Limited Appoints Hitesh Popatlal Oswal as the Additional Director CI
Zenlabs Ethica Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Zenlabs Ethica Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Zenlabs Ethica Limited Declares Interim Dividend, Payable on or Before August 18, 2022 CI
Zenlabs Ethica Limited Announces Appointment of Tanvi Chhabra as Company Secretary and Compliance Officer CI
Zenlabs Ethica Limited Announces Resignation of Divya Gupta as Company Secretary and Compliance Officer CI
Zenlabs Ethica Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Zenlabs Ethica Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Zenlabs Ethica Limited Announces Resignation of Chander Sheel Baweja from the Position of the Independent Director CI
Zenlabs Ethica Limited Announces Resignation of Directors CI
Zenlabs Ethica Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Zenlabs Ethica Limited Appoints Divya Gupta as the Company Secretary and Compliance Officer CI
Chart Zenlabs Ethica Limited
More charts
Zenlabs Ethica Limited is an India-based company, which deals in marketing and distribution of pharmaceutical products. The Company's divisions include Zenlabs, Coles Pharma and Mega Star. Its product categories include analgesics & anti-inflammatory, skin preparations, neurological disorders, eye, ear and nasal drops, anti-diabetic, anti-depressant, anti-infective, anti-emetic, steroid and anabolic steroid, anti-hypertensive drugs, anti-allergic, anti-cold and cough syrup, nutraceuticals, antacid, enzymes and appetite stimulant, ayurvedic preparation, git disorders, soap, and other pharmaceutical drugs. Its brands include RBC Red Super Active and Zenovit.
More about the company